Keyphrases
Acute Inflammation
11%
After Injection
100%
Age of Onset
11%
Anesthetized Rabbit
11%
Blepharospasm
22%
Cyclosporine
100%
Cytokine Release
11%
Dose Effect
11%
Dose-ranging
11%
Doxorubicin
100%
Doxorubicin Treatments
22%
Epithelial Damage
11%
Evans Blue
11%
Eyelid
44%
Eyelid Skin
100%
Healing
11%
Hemifacial Spasm
22%
High Dose
11%
Immunosuppressive Agents
11%
Inflammation
11%
Inflammatory Response
11%
Injection Site
22%
Muscle Fiber Loss
11%
Muscle Fiber number
11%
Muscle Loss
11%
Myotoxic
11%
Patient Acceptance
11%
Skin Injury
33%
Medicine and Dentistry
Blepharospasm
18%
Cyclosporine
100%
Cytokine Release
9%
Doxorubicin
100%
Drug Megadose
9%
Evans Blue
9%
Eyelid
100%
Hemifacial Spasm
18%
Immunosuppressive Drug
9%
Injection Site
18%
Injury
100%
Morphometrics
9%
Serositis
18%
Side Effect
9%
Skin Defect
9%
Skin Injury
27%
Pharmacology, Toxicology and Pharmaceutical Science
Blepharospasm
18%
Ciclosporin
100%
Cytokine
9%
Doxorubicin
100%
Evans Blue
9%
Hemifacial Spasm
18%
Immunosuppressive Agent
9%
Inflammation
27%
Injury
100%
Leporidae
27%
Side Effect
9%
Skin Defect
9%
Skin Injury
27%
Nursing and Health Professions
Blepharospasm
18%
Ciclosporin
100%
Doxil
100%
Drug Megadose
9%
Evans Blue
9%
Hemifacial Spasm
18%
Immunosuppressive Agent
9%
Inflammation
27%
Injection Site
18%
Injury
100%
Morphometry
9%
Side Effect
9%
Skin Defect
9%
Skin Injury
27%
Neuroscience
Blepharospasm
18%
Ciclosporin
100%
Doxorubicin
100%
Eyelid
100%
Immunosuppressive Drug
9%
Veterinary Science and Veterinary Medicine